Categories
Uncategorized

Sales of Pegfilgrastim Biosimilar Market to Exhibit 10% CAGR through 2026 | Fact.MR Study

Chemotherapy and/or radiotherapy is used for the treatment of most cancers. However, chemotherapy and radiotherapy have a very common side effect called neutropenia, and pegfilgrastim is required for its treatment. A study conducted on patients who received chemotherapy in 2016-2017 to evaluate the occurrence of chemotherapy-induced febrile neutropenia (CIFN) showed that, out of 200 patients, 9.5% patients developed neutropenia. Neutropenia patients are highly susceptible to infections, and for this reason, it is a life-threatening disease.  Pegfilgrastim is advantageous over filgrastim in relatively decreasing the incidence of febrile neutropenia. In the future, pegfilgrastim biosimilars will provide better access to this treatment.

For detailed insights on enhancing your product footprint, request for a sample here https://www.factmr.com/connectus/sample?flag=S&rep_id=1494

All in all, rising incidence of cancer and increasing use of chemotherapy for treatment will aid the expansion of the pegfilgrastim biosimilar market, which was valued at US$ 944 Mn in 2019, and is expected to exhibit a CAGR of over 10% over the forecast period (2020–2026).

Key Takeaways from Pegfilgrastim Biosimilar Market Study

  • The hospital pharmacies segment under the distribution channel category held half of the global pegfilgrastim biosimilar market share in 2019, owing to increasing cancer treatments such as chemotherapy and others. Retail pharmacies followed due to increasing number of prescriptions.
  • North America holds almost 3/4 of the global pegfilgrastim biosimilar market, followed by Europe, owing to large number of product launches in these regions.

For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=1494

  • The East Asia market year-on-year growth is expected to rapidly surge in the near future. This growth is due to increasing pool of patients and advancements in healthcare with government support, which will propel pegfilgrastim biosimilar market growth in Asian countries.
  • The COVID-19 pandemic that has swept the world is projected to have only a moderate impact on the progress of the pegfilgrastim biosimilar market.

“Increasing demand for cost-effective therapeutics such as biosimilars and patent expiration of blockbuster biologics will provide competitive benefits to market players in terms of new product development,” says a Fact.MR analyst.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/1494

Increasing Consolidation among Key Players and New Product Launches

Increase in value chain partnerships and market consolidation activities such as collaborations, partnerships, and M&A among market players will be a significant tool to increase their capabilities and speed to market for new launches. For instance, Mylan and Biocon collaboratively worked on a partnership to launch Pegfilgrastim biosimilar Fulphila.

Manufacturers are making efforts to develop biosimilars, and, so far, in 2020, there were 4 biosimilar launches in the United States, and many more are anticipated to be launched. It is estimated that, the pipeline from 2021 to 2025 will have at least 5 approved biosimilars.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/09/11/1914156/0/en/Ill-Effects-of-Self-medication-Practices-to-Ramp-up-the-Adoption-of-Earwax-Removal-Aids-Fact-MR.html

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:

4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
Tel: +1 (888) 863-5616
E-Mail: sales@factmr.com

Categories
Pharmaceutical

Rising Consumer Interest In Tone Enhancement To Have A Momentous Influence On The Growth Of The Aesthetic Medicine Market

250 Pages Aesthetic Medicine Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Aesthetic Medicine  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Aesthetic Medicine market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7139

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Aesthetic Medicine market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Aesthetic Medicine

The report offers actionable and valuable market insights of Aesthetic Medicine. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Aesthetic Medicine Market across various industries and regions

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7139

Key Takeaways from the Market Study

  • Non-invasive procedures segment to account for 53.7% of the market with a revenue of US$37.9 Bn in 2022.
  • In 2022, North America to contribute more than 41% market revenue.
  • An increase in awareness and demand for preventative procedures that provide anti-aging benefits of injectable medications early in life is expected to boost the aesthetic medicine market. Adults are self-conscious about their appearance.
  • With a market share of over US$6.8 billion, liposuction was the most major contributor in invasive procedures, while Botox injection was the most significant contributor in non-invasive procedures, with a market share of approximately US$9.5 Bn
  • Breast augmentation has witnessed a significant increase in the invasive procedure, which is expected to reach US$ 16.8 Bn by 2032 at a CAGR of 9.6%.

In recent years, non-invasive or minimally invasive procedures such as PRP, skin tightening, and medical facials have become more popular. Both new and old aesthetic medicine trends are expected to continue to grow in popularity, comments a Fact.MR analyst.

Competitive Analysis

  • The way in which competition is dealt with has changed considerably as market competition has expanded. The key companies in aesthetic medicine market include Allergan, Galderma Laboratories, Merz Pharmaceuticals, Alma Lasers, Johnson & Johnson, Galderma, Lumenis, Cynosure, Cutera, and Solta Medical

Some of the recent developments of aesthetic medicine providers are as follows:

  • In Jan 2021, Allergan Aesthetic established a partnership with Cypris Medical, a Chicago-based private medical device firm. The clinical trial has already begun, and it will aid in the evaluation and cross-checking of Xact’s safety in treating face skin drooping and nasolabial sulcus deepening. Allergan Aesthetics will be able to exercise an option to purchase Cypris Medical, which includes the Xact device.
  • In Dec 2021, Galderma announced that its new label for SCULPTRA (injectable poly-L-lactic acid (PLLA)) helps in treatment of smoothening of facial wrinkles, such as smile lines, includes higher dilution, the addition of immediate use reconstitution, and new injection techniques. These changes give aesthetic injectors more options for safely and successfully administering SCULPTRA.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/7139

Market Segments Covered in Aesthetic Medicines Industry Analysis :

  • By Procedure Type :

    • Invasive Procedures
      • Breast augmentation
      • Liposuction
      • Nose reshaping
      • Eyelid surgery
      • Tummy tuck
      • Other invasive procedures
    • Non-Invasive Procedures
      • Botox injections
      • Soft tissue fillers
      • Chemical peel
      • Laser hair removal
      • microdermabrasion
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Aesthetic Medicine Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Aesthetic Medicine Historical volume analysis: The report provides a comparison of Aesthetic Medicine ‘s historical sales and projected sales performance for 2021-2031.
  • Aesthetic Medicine Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Aesthetic Medicine   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Aesthetic Medicine Consumption by demographics: The report investigates consumer behavior affecting Aesthetic Medicine  demand outlook for the assessment period. Effect of their keenness for digital trends on Aesthetic Medicine  market is carefully analyzed
  • Post COVID consumer spending on Aesthetic Medicine : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Aesthetic Medicine market growth.

More Valuable Insights on Aesthetic Medicine  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Aesthetic Medicine , Sales and Demand of Aesthetic Medicine , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Rising Awareness Regarding Artificial Saliva Products Aiding Artificial Saliva Market Growth

250 Pages Artificial Saliva Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Artificial Saliva  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Artificial Saliva market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7297

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Artificial Saliva market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Artificial Saliva

The report offers actionable and valuable market insights of Artificial Saliva. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Artificial Saliva Market across various industries and regions

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7297

Report Attributes Details
Artificial Saliva Market Size (2020) US$ 667.9 Mn
Projected Year Value (2026) US$ 1.4 Bn
Global Market Growth Rate (2021-2026) 13.3% CAGR
China Market Growth Rate (2021-2026) 12.8%
Key Companies Profiled
  • Bausch Health Companies Inc.
  • Cipla Ltd.
  • Mission Pharmacal Company
  • GlaxoSmithKline PLC
  • ICPA Health Pvt. Ltd.
  • Forward Science
  • Fresenius Kabi AG
  • Midatech Pharma PLC
  • Perrigo Company PLC

Demand for oral sprays is expected to increase at 14.1% CAGR from 2021 to 2026 because they are very convenient to use and also cost-effective.

Competitive Landscape

As part of their efforts to strengthen their market position, artificial saliva product suppliers are pursuing partnership and joint venture tactics. In order to launch new product versions that will help them enhance their market presence, top artificial saliva product suppliers have been chasing approval bodies such as the FDA or the DCGA.

For instance :

  • In April 2021Mouth Kote-MD, a mouth spray based on MycoDelens, a proprietary substance created and licensed by New Mexico Tech University, was presented by Parnell Pharmaceuticals, Inc.

Full Access of this Exclusive Report is Available at-   https://www.factmr.com/checkout/7297

Key Segments Covered in Artificial Saliva Industry Research

  • Artificial Saliva Market by Product :

    • Oral Sprays
    • Oral Solutions
    • Oral Liquids
    • Gels
    • Powders
  • Artificial Saliva Market by Age Group :

    • Adults
    • Paediatrics
  • Artificial Saliva Market by Distribution Channel :

    • Hospital Pharmacies
    • Retail Pharmacies
    • Mail Order Pharmacies
    • Hypermarkets and Supermarkets
  • Artificial Saliva Treatment Market by Region :

    • North America Artificial Saliva Market
    • Europe Artificial Saliva Market
    • Asia Pacific Artificial Saliva Market
    • Latin America Artificial Saliva Market
    • MEA Artificial Saliva Market



Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

 

Report Benefits & Key Questions Answered

  • Artificial Saliva Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Artificial Saliva Historical volume analysis: The report provides a comparison of Artificial Saliva ‘s historical sales and projected sales performance for 2021-2031.
  • Artificial Saliva Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Artificial Saliva   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Artificial Saliva Consumption by demographics: The report investigates consumer behavior affecting Artificial Saliva  demand outlook for the assessment period. Effect of their keenness for digital trends on Artificial Saliva  market is carefully analyzed
  • Post COVID consumer spending on Artificial Saliva : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Artificial Saliva market growth.

More Valuable Insights on Artificial Saliva  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Artificial Saliva , Sales and Demand of Artificial Saliva , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Rising Prevalence of Autoimmune Diseases to Boost Tumor Necrosis Factor Inhibitors Market Revenue – Fact.MR Survey

250 Pages Tumor Necrosis Factor Inhibitors Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Tumor Necrosis Factor Inhibitors  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Tumor Necrosis Factor Inhibitors market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7302

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Tumor Necrosis Factor Inhibitors market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Tumor Necrosis Factor Inhibitors

The report offers actionable and valuable market insights of Tumor Necrosis Factor Inhibitors. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Tumor Necrosis Factor Inhibitors Market across various industries and regions

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7302

Report Attributes Details
Tumor Necrosis Factor Inhibitors Market Size (2020) US$ 41.6 Bn
Projected Year Value (2027) US$ 45.5 Bn
Global Market Growth Rate (2021-2027) 1.3% CAGR
China Market Growth Rate (2021-2027) 2.7%
Key Companies Profiled
  • AbbVie Inc.
  • Amgen Inc.
  • Innovent Biologics, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Biocad Biopharmaceutical Co.
  • Boehringer Ingelheim Pharmaceuticals, Inc.

Demand for the adalimumab drug class is projected to increase at the highest CAGR from 2021 to 2027. Rising R&D expenditure on adalimumab drugs are driving market growth.

Competitive Landscape

Tumor necrosis factor inhibitor providers are focused on the advancement and production of new products. To minimize side effects, increase their market share, and achieve traction in the global marketplace, market players are developing products using chemically stable ingredients.

For instance :

  • In December 2021, Rinvoq, an AbbVie medication, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of people with active psoriatic arthritis.


Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/7302

Key Segments Covered in TNF Inhibitors Industry Research

  • Tumor Necrosis Factor Inhibitors Market by Drug Class :

    • Adalimumab
    • Infliximab
    • Rituximab
    • Others
  • Tumor Necrosis Factor Inhibitors Market by Indication :

    • Rheumatoid Arthritis
    • Crohn’s Disease
    • Psoriasis
    • Others
  • Tumor Necrosis Factor Inhibitors Market by Distribution Channel :

    • Hospital Pharmacies
    • Specialty Pharmacies
    • Online Pharmacies
  • Tumor Necrosis Factor Inhibitors Market by Region :

    • North America TNF Inhibitors Market
    • Europe TNF Inhibitors Market
    • Asia Pacific TNF Inhibitors Market
    • Latin America TNF Inhibitors Market
    • MEA TNF Inhibitors Market



Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

 

Report Benefits & Key Questions Answered

  • Tumor Necrosis Factor Inhibitors Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Tumor Necrosis Factor Inhibitors Historical volume analysis: The report provides a comparison of Tumor Necrosis Factor Inhibitors ‘s historical sales and projected sales performance for 2021-2031.
  • Tumor Necrosis Factor Inhibitors Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Tumor Necrosis Factor Inhibitors   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Tumor Necrosis Factor Inhibitors Consumption by demographics: The report investigates consumer behavior affecting Tumor Necrosis Factor Inhibitors  demand outlook for the assessment period. Effect of their keenness for digital trends on Tumor Necrosis Factor Inhibitors  market is carefully analyzed
  • Post COVID consumer spending on Tumor Necrosis Factor Inhibitors : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Tumor Necrosis Factor Inhibitors market growth.

More Valuable Insights on Tumor Necrosis Factor Inhibitors  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Tumor Necrosis Factor Inhibitors , Sales and Demand of Tumor Necrosis Factor Inhibitors , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Rising Prevalence of Infectious Diseases to Stimulate Global Vancomycin Industry Growth -Fact.MR Survey

250 Pages Vancomycin Therapeutics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Vancomycin Therapeutics  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Vancomycin Therapeutics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=7293

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Vancomycin Therapeutics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Vancomycin Therapeutics

The report offers actionable and valuable market insights of Vancomycin Therapeutics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Vancomycin Therapeutics Market across various industries and regions

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7293

Report Attributes Details
Vancomycin Market Size (2020) US$ 313.7 Mn
Projected Year Value (2027) US$ 465.1 Mn
Global Market Growth Rate (2021-2027) 5.8% CAGR
China Market Growth Rate (2021-2027) 9.4%
Key Companies Profiled
  • Alvogen
  • MGB Biopharma Limited
  • Oragenics
  • Aphios Corporation
  • Microbiotix

Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.

Competitive Landscape

Vancomycin is a competitive and moderately fragmented market. There are many players in the sector under scrutiny, including both, small and large pharmaceutical companies. Furthermore, a wave of early-stage biotech companies has entered the market in response to developing antibiotic resistance.

For instance :

  • In February 2022Magnolia Medical Technologies, Inc., the producer of Steripath®, which is the only FDA 510(k)-complaint device platform for the reduction of blood culture contamination for sepsis testing1, revealed US$ 46 million of growth equity financing led by RTW Investments, LP (“RTW”), and Sectoral Asset Management.


Full Access of this Exclusive Report is Available at-

Key Segments Covered in Vancomycin Industry Research
  • Vancomycin Market by Type :
    • Daptomycin
    • Linezolid
    • Quinupristin
    • Ampicillin
    • Chloramphenicol
    • Others
  • Vancomycin Market by Application 
    • Sepsis
    • Lung Infection
    • Skin Soft Tissue Infection
    • Colitis & Intestinal Inflammation
    • Other Infections
  • Vancomycin Market by Region :
    • North America Vancomycin Market
    • Europe Vancomycin Market
    • Asia Pacific Vancomycin Market
    • Latin America Vancomycin Market
    • MEA Vancomycin Market


Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

 

Report Benefits & Key Questions Answered

  • Vancomycin Therapeutics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Vancomycin Therapeutics Historical volume analysis: The report provides a comparison of Vancomycin Therapeutics ‘s historical sales and projected sales performance for 2021-2031.
  • Vancomycin Therapeutics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Vancomycin Therapeutics   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Vancomycin Therapeutics Consumption by demographics: The report investigates consumer behavior affecting Vancomycin Therapeutics  demand outlook for the assessment period. Effect of their keenness for digital trends on Vancomycin Therapeutics  market is carefully analyzed
  • Post COVID consumer spending on Vancomycin Therapeutics : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Vancomycin Therapeutics market growth.

More Valuable Insights on Vancomycin Therapeutics  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Vancomycin Therapeutics , Sales and Demand of Vancomycin Therapeutics , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Surging Aging Population to Boost Consumption of Osteoporosis Therapeutic Drugs – Fact.MR Study

250 Pages Osteoporosis Therapeutics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Osteoporosis Therapeutics  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Osteoporosis Therapeutics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=7285

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Osteoporosis Therapeutics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Osteoporosis Therapeutics

The report offers actionable and valuable market insights of Osteoporosis Therapeutics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Osteoporosis Therapeutics Market across various industries and regions

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7285

The global osteoporosis therapeutics market stands at a valuation of US$ 12.7 Bn currently, and is predicted to reach US$ 14.2 Bn by the end of 2026.

Report Attributes Details
Osteoporosis Therapeutics Market Size (2022) US$ 12.7 Bn
Projected Year Value (2026F) US$ 14.2 Bn
Global Market Growth Rate (2022-2026) 2.9% CAGR
United States Market Share (2022) 41%
Key Companies Profiled

Consumption of osteoporosis therapeutic drugs is anticipated to increase at a CAGR of 2.9% from 2022 to 2026.

Competitive Landscape :

Osteoporosis drug manufacturers are increasing their investments in the research and development of novel drugs to fast-track new launches. Osteoporosis treatment injections are gaining popularity and market players are trying to launch these to advance their revenue potential in the global market.

  • In October 2021Entera Bio, a leading biotechnology company, posted crucial data for its oral osteoporosis drug formulation trial that is in its mid-stage. The company moved ahead to phase 3 registration of this study.


Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/7285

Key Segments Covered in Osteoporosis Therapeutics Industry Research

  • Osteoporosis Therapeutics Market by Drug Class :
    • Bisphosphonates
    • Selective Estrogen Inhibitor Modulators (SERM)
    • Parathyroid Hormone Therapies
    • Calcitonin
    • Rank Ligand Inhibitors
  • Osteoporosis Therapeutics Market by Route of Administration :
    • Oral Osteoporosis Therapeutics
    • Injectable Osteoporosis Therapeutics
    • Other Routes of Administration
  • Osteoporosis Therapeutics Market by Region :
    • North America Osteoporosis Therapeutics Market
    • Latin America Osteoporosis Therapeutics Market
    • Europe Osteoporosis Therapeutics Market
    • East Asia Osteoporosis Therapeutics Market
    • South Asia & Oceania Osteoporosis Therapeutics Market
    • Mea Osteoporosis Therapeutics Market


Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

 

Report Benefits & Key Questions Answered

  • Osteoporosis Therapeutics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Osteoporosis Therapeutics Historical volume analysis: The report provides a comparison of Osteoporosis Therapeutics ‘s historical sales and projected sales performance for 2021-2031.
  • Osteoporosis Therapeutics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Osteoporosis Therapeutics   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Osteoporosis Therapeutics Consumption by demographics: The report investigates consumer behavior affecting Osteoporosis Therapeutics  demand outlook for the assessment period. Effect of their keenness for digital trends on Osteoporosis Therapeutics  market is carefully analyzed
  • Post COVID consumer spending on Osteoporosis Therapeutics : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Osteoporosis Therapeutics market growth.

More Valuable Insights on Osteoporosis Therapeutics  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Osteoporosis Therapeutics , Sales and Demand of Osteoporosis Therapeutics , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Rapid Integration of Artificial Intelligence To Surge Stroke Post Processing Software Market 2032

Fact.MR’s recently published study on the stroke post processing software market concludes that the industry is expected to flourish at a CAGR of 8.9% from 2022 to 2032, reaching US$ 417.53 Mn by the end of the said forecast period. Advancements in healthcare IT infrastructure to improve patient outcomes is the chief growth driver of this market.

From 2015 to 2021, sales of stroke post processing software grew at a CAGR of 9.2%, reaching US$ 141 Mn. As of 2022, the market is forecast to reach US$ 178 Mn. Initially, growth prospects were dented during Q1 2020, amid reallocation of all healthcare resources to COVID-19 patients. Eventually, linkages between strokes and the coronavirus diseases prompted increased uptake of post processing software.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7133

In coming years, part of early-career stroke neurologists’ role will be to integrate AI and smart technology into stroke research and practice. The application of AI technology in the assessment of stroke risk can achieve favorable results.  The need for early detection, accurate diagnosis, and timely treatment has promoted the increasing application of AI in stroke care. AI systems can also help stroke neurologists identify patients with acute ischemic stroke due to large vessel occlusions.

Key Takeaways from the Market Study

  • Desktop mounted software to accumulate 62% market revenue as of 2022
  • Mobile and tablet based software to experience a CAGR of 8.7% from 2022 to 2032
  • By modality, MRI-based stroke post processing software to account for 71% revenue
  • Over 4/5th of global market revenue to be contributed by ischemic strokes
  • Hospitals & clinics to contribute more than 3 out of 4 sales of stroke post processing software
  • North America to be a lucrative market for stroke post processing software, accumulating 47% revenue
  • Asia Pacific to flourish at over 9% value CAGR from 2022 to 2032

As healthcare providers look to improve patient outcomes, the emphasis on digitally driven patient care is augmenting manifold. This has led to extensive stroke post processing software deployment, providing fertile ground for new software launches, remarks a Fact.MR analyst.

Need more information about Report Methodology? Click here-   https://www.factmr.com/connectus/sample?flag=RM&rep_id=7133

Competitive Landscape

Siemens Healthineers, General Electric Company, Brainomix Limited, iSchemaView and Viz.ai Inc. are some of the prominent stroke post processing software providers profiled by Fact.MR. Aforementioned players are strengthening AI capabilities to offer highly precise imaging systems. Prominent developments are as follows:

  • In January 2022, Brainomix Limited launched the e-Stroke 11 AI-powered stroke imaging platform. This software is designed to enhance stroke network communications by allowing physicians to quickly and securely access, review and share images and patient data, send messages and flag patients eligible for thrombectomy
  • In February 2022, Viz.ai Inc. and TeleSpecialists LLC entered a strategic partnership to bring together AI-powered stroke care and leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States. This partnership will facilitate stroke care coordination even when the patient and provider are hundreds of miles apart.
Report Attributes Details
Market Value as of 2021 US$ 141 Mn
Expected Market Value in 2022 US$ 178 Mn
Projected Market Value in 2032 US$ 417.53 Mn
Global Growth Rate (2022-2032) 8.9% CAGR
Market Share of North America 47%
Expected Growth Rate of Asia Pacific 9.3% CAGR
Proportion of Stroke Post Processing Software Usage in Hospitals & Clinics 76%
Key Providers of Stroke Post Processing Software
  • Siemens Healthineers
  • General Electric Company
  • Brainomix Limited
  • iSchemaView
  • Viz.ai Inc.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/7133

Key Segments Covered in the Stroke Processing Industry Study

  • By Installation

    • Desktop-based Stroke Post Processing Software
    • Mobile Phones & Tablet-based Stroke Post Processing Software
  • By Modality

    • CT Scan-based Stroke Post Processing Software
    • MRI-based Stroke Post Processing Software
  • By Software Type

    • Stroke Post Processing Software for Ischemic Stroke
    • Stroke Post Processing Software for Hemorrhagic Stroke
    • Stroke Post Processing Software for Other Diseases
  • By End Use

    • Stroke Post Processing Software for Hospitals & Clinics
    • Stroke Post Processing Software for Specialty Centers & Others

Key Drivers Influencing Stroke Post Processing Software Uptake

Ever Increasing Global Burden of Strokes Providing Growth Opportunities

According to the World Stroke Organization (WSO), from 1990 to 2019, the burden of strokes in absolute number of cases increased substantially, with a 70% increase in incident strokes, 43% in terms of deaths, 102% prevalent strokes and 143% in terms of DALYs. The estimated global cost of stroke is over US$ 721 billion, or 0.66% of global GDP.

A majority of this global burden (86% in terms of deaths and 89% in terms of DALYs) is concentrated across the lower-income and lower-middle-income countries. Given these highly disturbing trends, it is unsurprising to know that the importance of providing advanced stroke care and management has heightened in recent years.

Both governments and healthcare organizations have left no stone unturned to ensure that good quality care is administered to stroke patients. This has led to enhanced deployment of stroke post processing software across both large and small-scale healthcare settings. A majority of these software solutions have been designed to cater to the needs of ischemic stroke patients, the most prevalent category of stroke.

Rapid Integration of Artificial Intelligence in Stroke Management Widening Prospects

The global healthcare industry is in the middle of an artificial intelligence revolution. With the rapid development of deep learning and machine learning algorithms in recent years, the application of AI in diagnosis, risk stratification, and therapeutic decision-making has become ever-more widespread. AI presents exciting opportunities to improve stroke care delivery.

In coming years, part of early-career stroke neurologists’ role will be to integrate AI and smart technology into stroke research and practice. The application of AI technology in the assessment of stroke risk can achieve favorable results. Previous research showed that AI algorithms can be used for early diagnosis of atrial fibrillation using normal sinus rhythm electrocardiographs, which allows for early intervention to reduce stroke risk.

The need for early detection, accurate diagnosis, and timely treatment has promoted the increasing application of AI in stroke care. AI systems can also help stroke neurologists identify patients with acute ischemic stroke due to large vessel occlusions. The Rapid AI system has been proved to be an efficient tool in identifying candidates who can benefit from reperfusion therapy, such as endovascular therapy and intravenous recombinant tissue-type plasminogen activator.

Read More Trending Reports of Fact.MR-  https://www.prnewswire.com/news-releases/rising-demand-for-breast-augmentation-to-account-for-nearly-45-of-autologous-fat-grafting-factmr-301273860.html

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market

Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market

Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Japan Sales Office
Neha Bhosle, 4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
E: sales@factmr.com

Categories
Pharmaceutical

Increasing Incidence of Neural Disorders Is Driving Induced Pluripotent Stem Cell (iPSC) Demand – Fact.MR Study

250 Pages Induced Pluripotent Stem Cell (iPSC) Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Induced Pluripotent Stem Cell (iPSC)  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Induced Pluripotent Stem Cell (iPSC) market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7298

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Induced Pluripotent Stem Cell (iPSC) market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Induced Pluripotent Stem Cell (iPSC)

The report offers actionable and valuable market insights of Induced Pluripotent Stem Cell (iPSC). The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Induced Pluripotent Stem Cell (iPSC) Market across various industries and regions

Need more information about Report Methodology? Click here –  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7298

Report Attributes Details
Induced Pluripotent Stem Cell Market Size (2022) US$ 1.8 Bn
Projected Year Value (2026F) US$ 2.3 Bn
Global Market Growth Rate (2022-2026) 6.6% CAGR
United States Market Worth (2022) US$ 820.4 Mn
Key Companies Profiled
  • Sumitomo Dainippon Pharma Co. Ltd.
  • FUJIFILM Cellular Dynamics Inc.
  • Ncardia
  • REPROCELL USA Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Axol Bioscience Ltd.
  • ViaCyte Inc.
  • Cynata Therapeutics Limited
  • Pluricell Biotech
  • Evotec SE
  • Fate Therapeutics Inc.

Over the 2022 to 2026 period, worldwide demand for induced pluripotent stem cells is anticipated to rise rapidly at a CAGR of 6.6%. The China iPSC market is expected to surge ahead at a CAGR of 8.5% over the same time frame.

Competitive Landscape :

Induced pluripotent stem cell suppliers are increasing their investments in research and development to advance their offerings in stem cell therapies which are gaining popularity for the treatment of multiple chronic diseases.

  • In April 2022, TreeFrog Therapeutics, a biotechnology firm focused on making affordable stem cell therapies, announced the launch of a grant worth US$ 100,000. The Stem Cell SpaceShot Grant will be open to PhD-level scientists and students to advance stem cell biology research and promote scientific discoveries.


Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/7298

Key Segments Covered in Induced Pluripotent Stem Cell Industry Research

  • iPSC Market by Cell Type :

    • Vascular Cells
    • Cardiac Cells
    • Neuronal Cells
    • Liver Cells
    • Immune Cells
    • Other Cell Types
  • iPSC Market by Research Method :

    • Cellular Reprogramming
    • Cell Culture
    • Cell Differentiation
    • Cell Analysis
    • Cellular Engineering
    • Other Research Methods
  • iPSC Market by Application :

    • iPSC for Drug Development & Toxicology Testing
    • iPSC for Academic Research
    • iPSC for Regenerative Medicine
    • Other Applications
  • iPSC Market by Region :

    • North America Induced Pluripotent Stem Cell Market
    • Latin America Induced Pluripotent Stem Cell Market
    • Europe Induced Pluripotent Stem Cell Market
    • East Asia Induced Pluripotent Stem Cell Market
    • South Asia & Oceania Induced Pluripotent Stem Cell Market
    • MEA Induced Pluripotent Stem Cell Market



Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

 

Report Benefits & Key Questions Answered

  • Induced Pluripotent Stem Cell (iPSC) Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Induced Pluripotent Stem Cell (iPSC) Historical volume analysis: The report provides a comparison of Induced Pluripotent Stem Cell (iPSC) ‘s historical sales and projected sales performance for 2021-2031.
  • Induced Pluripotent Stem Cell (iPSC) Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Induced Pluripotent Stem Cell (iPSC)   It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Induced Pluripotent Stem Cell (iPSC) Consumption by demographics: The report investigates consumer behavior affecting Induced Pluripotent Stem Cell (iPSC)  demand outlook for the assessment period. Effect of their keenness for digital trends on Induced Pluripotent Stem Cell (iPSC)  market is carefully analyzed
  • Post COVID consumer spending on Induced Pluripotent Stem Cell (iPSC) : Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Induced Pluripotent Stem Cell (iPSC) market growth.

More Valuable Insights on Induced Pluripotent Stem Cell (iPSC)  Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Induced Pluripotent Stem Cell (iPSC) , Sales and Demand of Induced Pluripotent Stem Cell (iPSC) , analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand For Cordless Personal Water Flossers Is Expected To Expand At A CAGR Of 7% By 2031

The study on the Global Personal Dental Water Flosser Market Insights published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of Personal Dental Water Flosser Market Insights in the upcoming years. Further, the study dives deep to investigate the micro and macro-economic parameters that are expected to influence the global scenario of the Personal Dental Water Flosser Market Insights during the forecast period (2021-2031).

The report examines the current trends, growth opportunities, restraints, and market drivers that are projected to influence the overall dynamics of the Personal Dental Water Flosser Market Insights in the assessment period.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=6453                                       

Personal Dental Water Flosser Market Insights Segmentation

  • On the Basis of Product:
    • Cordless Personal Dental Water Flossers
    • Countertop Personal Dental Water Flossers
  • On the Basis of Sales Channel:
    • Personal Dental Water Flossers Sold through Offline Stores
    • Personal Dental Water Flossers Sold through Online Stores

Request Customization  https://www.factmr.com/connectus/sample?flag=RC&rep_id=6453                                                               

Essential Takeaways from the Personal Dental Water Flosser Market Insights Report

  • Comparison of prominent players operating in the Personal Dental Water Flosser Market Insights.
  • Recent developments and key strategies adopted by market players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain of the Personal Dental Water Flosser Market Insights.
  • Growth opportunities for emerging market players in various regional markets.
  • Current trends influencing the scenario of the Personal Dental Water Flosser Market Insights.

Important queries related to the Personal Dental Water Flosser Market Insights addressed in the report:

  1. Who are the most prominent players in the Personal Dental Water Flosser Market Insights?
  2. What are the factors that are likely to hinder the growth of the Personal Dental Water Flosser Market Insights during the forecast period (2021-2031)?
  3. Why is the concentration of tier-1 companies high in specific region?
  4. How are the soaring prices of raw materials impacting the demand for keyword?
  5. Why are market players eyeing opportunities in particular region?

Buy Now  https://www.factmr.com/checkout/6453                                                                          

Why Choose Fact.MR

  • One of the most established market research companies in India
  • Round the clock customer support for clients across the globe
  • Tailor-made reports available without additional costs
  • Analysis of markets in over 150 countries
  • Data collected from credible primary and secondary sources

For More Insights-https://www.globenewswire.com/news-release/2022/03/09/2400432/0/en/Low-Code-Development-Industry-is-Projected-to-Achieve-a-Global-Market-Size-of-US-187-Bn-by-2032-Currently-US-Accounts-For-the-Largest-Market-Share-in-the-World.html

About Fact.MR        

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:                                                                   
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Categories
Pharmaceutical

The Global Sales Of Animal Vaccines Is Forecast To Garner A Market Value Of US$ 12 Bn In 2022

Fact.MR states the global sales of animal vaccines are expected to surpass US$ 29 Bn by registering a positive CAGR of 9.2% in the forecast period 2022-2032. Food and clothing industry largely depends on animals for milk, meat and wool. Thus, animal safety has become important. Moreover, increase in canine disorders are a major concern in animals. To avoid the same, the demand for animal vaccines has increased.

Historically, from 2015 to 2021, the global sales of animal vaccines expanded at a CAGR of 8.6%, closing at a value of US$ 11 Bn. The COVID-19 pandemic further reinforced the need to increase production of animal vaccines, amid the fear of contracting the virus from animals. Thus, governments of various countries focused on vaccinating animals. This, in turn, is increasing the sales of animal vaccines.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=7123

Furthermore, increasing investment in research and development by key players is positively influencing the demand for animal vaccines. In addition, rapidly growing livestock population is fueling the growth of animal vaccines. Thus, the aforementioned factors are expected to boost the sales of animal vaccines.

Key Takeaways from the Market Study

  • By product, attenuated live vaccines expected to hold more than 30% market share for animal vaccines.
  • Livestock expected to hold more than 65% market share for animal vaccines
  • North America expected to hold more than 23% market share for animal vaccines.
  • Asia Pacific expected to possess more than 20% market share for animal vaccines.
  • Global animal vaccines market demand to be valued US$ 12 Bn by the end of 2022

“Frequent episodes of outbreaks of zoonotic diseases and their transmission to humans has highlighted the importance of maintaining animal health. This has widened expansion prospects for animal vaccines, prompting animal health specialists to conduct various clinical trials of multiple vaccine formulations,” states a Fact.MR analyst.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=7123

Key Segments Covered in the Animal Vaccines Industry Report

  • By Product

    • Attenuated Live Animal Vaccines
    • Recombinant Animal Vaccines
    • DNA Animal Vaccines
    • Inactivated Animal Vaccines
    • Subunit Animal Vaccines
  • By Animal Type

    • Livestock Animal Vaccines
      • Poultry
      • Ruminants
      • Swine
      • Aqua
    • Companion Animal Vaccines
      • Canine
      • Feline
      • Others
  • By Route of Administration

    • Subcutaneous Administration of Animal Vaccines
    • Intranasal Administration of Animal Vaccines
    • Intramuscular Administration of Animal Vaccines

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/7123

 

Report Attributes Details
Market Size Value in 2021 US$ 12 Bn
Project Market Forecast Value in 2032 US$ 29 Bn
Global Growth Rate (2022-2032) 9.2%
Market Share of North America 33%
Key Companies Profiled
  • Merck & Co. Inc.
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Biogenesis Bago
  • Indian Immunologicals Ltd.
  • Elanco Animal Health Incorporated
  • CEVA Animal Health (Pty) Ltd.
  • Phibro Animal Health Corporation
  • NEOGEN Corporation

An increase in the outbreak of disease amongst cattle along with canine disorders is boosting the sales of animal vaccines. Moreover, investment in research and development by government of different countries is positively influencing the demand for animal vaccines.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market

Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market

Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Japan Sales Office
Neha Bhosle, 4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
E: sales@factmr.com